Cell Therapy News/Articles, page-5699

First 5699 Last

Share
Profile

Follow
Bazsa

3,956 Posts.

1357

16/08/20

09:43

Post #: 46571112
Share

Originally posted by benelong: ↑

Very interesting video. Thanks to the several contributors.

I usually ignore semi-informed declarations such as revealed in this video. I daresay the majority of readers here are also hugely sceptical of information that could only have been leaked. Most of us are confident that the organisers of the trial and the professional participants in the hospitals and MSB, above all, are acutely conscious of the need to maintain trial integrity and FDA support by not breaching confidentially.

And anyway, each of the numerous trial sites has only a tunnel view of he progress of their patients and they don't know what proportion of the patients under their care are in one or other cohort. So, I doubt there has been an accurate leak.

But.....but....., those numbers the presenter quoted are intriguing. And that's taking her literally as saying 75 PERCENT of 90 patients with moderate to severe ARDS, (not 75 by number), have been taken off ventilators. The 75% is a very nice fit with our expectations.

What are our expectations? A couple of our most respected posters have noted that improved standard of care for all patients should improve survival for the control group.
As many as 60% of them might now survive, a great improvement over the previous woeful number.
And with the improved SOC let's allow that the Rem-L. cohort survival improves Mt Sinai's small trial result from 83% to 90% survivors.

So, we would think that a very possible result for MSB in the current RCT could be 60% survivors of 45 controls (= 27 survivors) and 90% of 45 in the Rem-L. group ( = 40.5). Total survivors = 67.5. Which just happens to be exactly the 75% of 90 patients in the video.
To make sure, let's apply our theoretical, expected, but quite possible results to the video's quote.

She said 75% of 90. That's 67.5 off ventilators. So how many in each cohort?

Rem-L cohort: 90% survived of 45 patients = 40.5 survivors.

Control group: 60% survived of 45 patients = 27 survivors.

Total = 67.5 survivors. What a nice fit with our expectations.

Coincidence? Or a setup?

I state very clearly here that I strongly doubt there has been a credible leak. And why would it only be revealed in this relative backwater source? There is another possible reason for the video numbers.

I'm no conspiracy theorist but I do know that the sharemarket in general and the pharma area in particular can be a dirty game. So we need to be aware that some upramper could have observed respected commentators quote the 60%/90% possible results, applied them to the fact that we know 90 subjects have been treated, added the "75% off ventilators", and waited for someone with too much time on their hands Sunday morning, like me, to excite the market.
Beware the pump and dump. While these numbers are intriguing, they may be more than a coincidence. I won't let them change my investment plan.

Expand

Very much sub standard and miss leading report. Perhaps she is referring to the EAP?
I will wait for MSB to do the announcement.

MSB Price at posting: $4.70 Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

IRE

Iress runs 'hot' for Wealth Within's stock tips

Failure to report prompts ASX to impose multiple company suspensions

There are more pages in this discussion • 12,547 more messages in this thread...

First 5699 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.21		Change 0.040(3.42%)		Mkt cap ! $1.381B

Open	High	Low	Value	Volume
$1.17	$1.22	$1.17	$5.683M	4.776M

Buyers (Bids)

No.	Vol.	Price($)
1	20000	$1.21

Sellers (Offers)

Price($)	Vol.	No.
$1.21	19746	3

View Market Depth

No.	Vol.	Price($)
1	20000	1.205
2	55500	1.200
3	60292	1.195
1	33180	1.190
3	67965	1.185

Price($)	Vol.	No.
1.210	19746	3
1.215	45236	7
1.220	190559	15
1.225	70181	4
1.230	169274	5

Last trade - 16.10pm 01/10/2024 (20 minute delay)

MSB (ASX) Chart

Cell Therapy News/Articles, page-5699

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Iress runs 'hot' for Wealth Within's stock tips

Failure to report prompts ASX to impose multiple company suspensions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Cell Therapy News/Articles, page-5699

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Iress runs 'hot' for Wealth Within's stock tips

Failure to report prompts ASX to impose multiple company suspensions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News